Evidence map›Paper›PMID 32325753›Full record

ReviewJournal of clinical medicine2020

Caffeine, a Risk Factor for Osteoarthritis and Longitudinal Bone Growth Inhibition.

María Guillán-Fresco, Eloi Franco-Trepat, Ana Alonso-Pérez, Alberto Jorge-Mora, Miriam López-Fagúndez, Andrés Pazos-Pérez, Oreste Gualillo, Rodolfo Gómez

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Microbiology spectrum · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

María Guillán-FrescoMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, SERGAS, 15706 Santiago de Compostela, Spain.ORCID 0000-0002-6269-5130
Eloi Franco-TrepatMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, SERGAS, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-7514-4672
Ana Alonso-PérezMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, SERGAS, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-5830-0960
Alberto Jorge-MoraMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, SERGAS, 15706 Santiago de Compostela, Spain.ORCID 0000-0003-0143-1323
Miriam López-FagúndezMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, SERGAS, 15706 Santiago de Compostela, Spain.ORCID 0000-0002-4577-737X
Andrés Pazos-PérezMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, SERGAS, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-8598-9476
Oreste GualilloResearch Laboratory 9, Institute of Medical Research, SERGAS, Santiago University Clinical Hospital, 15706 Santiago de Compostela, Spain.ORCID 0000-0002-7154-1328
Rodolfo GómezMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, SERGAS, 15706 Santiago de Compostela, Spain.ORCID 0000-0002-1309-1023
Instituto de Investigación Sanitaria de Santiago · ES

Funding

Fundación Mutua Madrileña MMA 2018Horizon 2020 MSCA-Q4 RISE-H2020 734899Instituto de Salud Carlos III CP15/00007Instituto de Salud Carlos III PI16/01870Instituto de Salud Carlos III RD16/0012/0014
6 · The paper itself

Abstract

Osteoarthritis (OA), the most common chronic rheumatic disease, is mainly characterized by a progressive degradation of the hyaline articular cartilage, which is essential for correct joint function, lubrication, and resistance. Articular cartilage disturbances lead to joint failure, pain, and disability. Hyaline cartilage is also present in the growth plate and plays a key role in longitudinal bone growth. Alterations of this cartilage by diverse pathologies have been related to longitudinal bone growth inhibition (LBGI), which leads to growth retardation. Diet can play a crucial role in processes involved in the OA and LBGI's onset and evolution. Specifically, there is ample evidence pointing to the negative impacts of caffeine consumption on hyaline cartilage. However, its effects on these tissues have not been reviewed. Accordingly, in this review, we summarize all current knowledge in the PubMed database about caffeine catabolic effects on articular and growth plate cartilage. Specifically, we focus on the correlation between OA and LBGI with caffeine prenatal or direct exposure. Overall, there is ample evidence indicating that caffeine intake negatively affects the physiology of both articular and growth plate cartilage, increasing consumers predisposition to suffer OA and LBGI. As a result, caffeine consumption should be avoided for these pathologies.

Indexed as

articular cartilagecaffeinecatabolismgrowth plate cartilagegrowth retardationlong bone growth inhibitionosteoarthritis

Identifiers

PMID32325753
PMCPMC7230935
OpenAlexW3017212898

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.